Prognostic Factors for All Types of Cancer Combined

The purpose of this study is to investigate every possible applicability of flow cytometrical analysis in the intracellular detection of tumor-related material in activated macrophages in the broadest range of cancer types.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Atrium Medical Centre Parkstad, Heerlen, Limburg, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(Suspicion of) presence of cancer in the broadest sense of the word
Must be able to understand and sign written informed consent

Exclusion criteria

None

Treatment and study plan

Primary outcomes

screening and followup

Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Atrium Medical Center

Other

Collaborators

Maastricht University Medical Center

Registry information

Official study title

Flow Cytometrical Analysis of the Human Immune System to Assess Tumor-related Material Piling up in Activated Macrophages in All Relevant Cancer Types.

Acronym: ProFaCo

Important dates

Study start: 2006
Primary completion: 2015
Study completion: 2015
First posted: Jun 25, 2008
Registry last updated: Apr 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed